type I clear glass vial with a fluoropolymer-faced

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients with Congenital Hyperinsulinism

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ersodetug in Patients with Inadequately Controlled Hypoglycemia Due to Tumor-Associated Hyperinsulinism (tumorHI)